ProCE Banner Activity

CE / CME

Diagnosing TD in Clinical Practice

Multimedia
Watch one of the world’s leading experts explore the diagnostic dilemmas and etiology of tardive dyskinesia. This symposium will also address the prevalence, screening and evidence-based treatments for TD.

Pharmacists : 1.00 contact {hour} ({0.1} CEUs)

Physicians : maximum of 1.00 AMA PRA Category 1 {Credit}

Physician Assistants : maximum of 1.00 {hour} of AAPA Category I (Preapproved) {credit}

Released: March 15, 2020

Expiration: March 15, 2021

No longer available for credit.

Share

Faculty

Jonathan M Meyer

Jonathan M Meyer, MD, DLFAPA

Voluntary Clinical Professor of Psychiatry 
University of California, San Diego
Senior Academic Advisor
California Department of State Hospitals
San Diego, California

Thomas L. Schwartz

Thomas L. Schwartz, MD

Professor and Chair of Psychiatry and Behavioral Sciences
SUNY Upstate Medical University
Syracuse, New York

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an independent educational grant from

Neurocrine Biosciences

Partners

GME

ProCE Banner

Target Audience

This activity is intended for physicians, physician assistants, nurse practitioners and registered nurses engaged in the care of patients with tardive dyskinesia.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Discuss the prevalence and diagnostic criteria for TD in psychiatric patients
  • Identify TD using the AIMS examination
  • Formulate evidence based treatments for TD, considering both efficacy and tolerability

Disclosure

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty Disclosure

Primary Author

Jonathan M Meyer, MD, DLFAPA

Voluntary Clinical Professor of Psychiatry 
University of California, San Diego
Senior Academic Advisor
California Department of State Hospitals
San Diego, California

Consulting Fees: Acadia, Alkermes, Allergan, Intra-Cellular Therapies, Janssen

Speakers Bureau: Acadia, Alkermes, Janssen, Merck, Neurocrine, Otsuka, Sunovion, Teva

Thomas L. Schwartz, MD

Professor and Chair of Psychiatry and Behavioral Sciences
SUNY Upstate Medical University
Syracuse, New York

Royalties: Cambridge University Press, Taylor & Francis Group

Additional Information

Program Medium

This program has been made available online.